What it means
Longevity escape velocity (LEV) is the hypothetical moment when life expectancy increases by more than one year for every calendar year, so that a person alive at that point never catches up with their own death — each year, medicine adds more than a year. The term was popularised by Aubrey de Grey and David Gobel in the 2000s; the mechanism imagined is a series of rejuvenation therapies — senolytics, stem-cell replacement, epigenetic reprogramming — each extending life long enough for the next to arrive.
It is a mathematical idea about rates of progress, not a biological finding.
Why it matters for longevity
The concept frames a real question — is ageing a solvable engineering problem or a biological ceiling — and it drives investment in companies working on epigenetic reprogramming and senescent-cell clearance. For an individual it matters in one practical way: the bet that staying healthy now keeps you eligible for whatever arrives later is a reasonable reason to protect healthspan aggressively, whether or not LEV ever happens.
What the evidence says
The data do not show it. Life expectancy at birth in rich countries rose about 2–3 years per decade through the twentieth century — roughly a quarter of a year per year — and the gains have slowed since 1990 (Olshansky 2024, Nature Aging); in the US they stalled and then fell during the pandemic. Maximum verified lifespan has not exceeded 122 since 1997, and the mortality rate at extreme ages appears to plateau rather than fall.
On the therapy side, epigenetic reprogramming (Yamanaka-factor cocktails) has reversed age markers in mice (Ocampo 2016, Lu 2020) and restored vision in old mice; the first human trials are starting. Senolytics and rapamycin have mouse lifespan data and no human lifespan data. Nothing in the pipeline has shown, in a person, a change in lifespan.
How to measure or use it
- Not measurable, by definition. The things that would make a person eligible for future therapies are the ones already measurable: VO2max, ApoB, HbA1c, lean mass, sleep.
- A useful filter: any product or clinic that uses "escape velocity" in its marketing is selling a forecast, not a result.
- The honest version of the bet: do what the cohorts show extends healthspan now; treat the rest as interesting news.
Related
- What is healthspan? — the measurable version of the ambition
- The longevity drugs — the candidates in the pipeline
- How to build a longevity protocol — the practical bet
Frequently asked questions
Will longevity escape velocity happen?
No evidence suggests it is near. Life-expectancy gains have slowed, maximum lifespan has not moved since 1997, and no therapy has extended human lifespan in a trial.
Who coined the term?
Aubrey de Grey and David Gobel popularised it in the mid-2000s in connection with proposed rejuvenation therapies.
What should I do about it?
Protect healthspan with the evidenced levers. That is the only part of the bet you can act on, and it pays off whether or not the forecast does.
Want this applied to your own numbers?
Fifteen minutes of intake, your labs, a human-reviewed protocol within about 24 hours, three documents, a free coach call and check-ins through the cycle. €399, follow-up included.
Build my protocol Book a 15-minute call